Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-YMLDL^QPETT-OH
3D-Ansicht

Biosynth logo

H-YMLDL^QPETT-OH

Ref. 3D-PP43487

Unbestimmte GrößeNachfragen
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 12. Dezember 2024

Produktinformation

Name:
H-YMLDL^QPETT-OH
Synonyme:
  • NH2-Tyr-Met-Leu-Asp-Leu^Gln-Pro-Glu-Thr-Thr-OH
Beschreibung:

Peptide H-YMLDL^QPETT-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YMLDL^QPETT-OH include the following: T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor YS Lee, TS Kim, DK Kim - BMC cancer, 2011 - Springerhttps://link.springer.com/article/10.1186/1471-2407-11-225 Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo YC Song , AH Chou, A Homhuan - Journal of Leukocyte , 2011 - academic.oup.comhttps://academic.oup.com/jleukbio/article-abstract/90/2/323/6960320 Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical WMJ Schoell, R Mirhashemi, B Liu, MF Janicek - Gynecologic , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S009082589995504X Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial WJ Van Driel, ME Ressing, GG Kenter - European journal of , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0959804999000489 Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations WF Cheng, CN Lee, YN Su, MC Chang - , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2005.02126.x Linear epitope prediction in HPV type 16 E7 antigen and their docked interaction with human TMEM 50A structural model U Srivastava , S Singh, B Gautam , P Yadav - , 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498776/ Use of fluorogenic histocompatibility leukocyte antigen-A* 0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous SJ Youde, PRR Dunbar , EML Evans, AN Fiander - Cancer research, 2000 - AACRhttps://aacrjournals.org/cancerres/article-abstract/60/2/365/506850 Cross-typic specificity and immunotherapeutic potential of a human HPV16 E7-specific CTL line SJ Youde, CM McCarthy, KJ Thomas - Journal of Cancer, 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20779 A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo SH Tu, HI Huang , SI Lin, HY Liu, YP Sher - Journal of , 2012 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/FullText/2012/04000/A_Novel_HLA_A2_restricted_CTL_Epitope_of.4.aspx Study on phenotype and function of antigen-specific CD8+ cytotoxic T cells induced by HPV 16 E7 peptide in vitro. QQF Qian QiFeng, LFG Li FangGu, LQ Li Qing - 2010 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20103227892 detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic N Cools , P Ponsaerts , M Lenjou, G Nijs - Molecular Cancer, 2006 - Springerhttps://link.springer.com/article/10.1186/1476-4598-5-49 A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7 (11-20) cytotoxic T lymphocyte epitope MWJ Schreurs, EWM Kueter, KBJ Scholten - Vaccine, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X05003804 Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway ML Mora-Garcaca­a , LR acavila-Ibarra, R Garcaca­a-Rocha - Cellular , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874917301363 Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone ML Mora-Garcaca­a , A Duenas-Gonzalez - Journal of Translational , 2006 - Springerhttps://link.springer.com/article/10.1186/1479-5876-4-55 Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions M de Lourdes Mora-Garcaca­a , R Garcaca­a-Rocha - Journal of Translational , 2016 - Springerhttps://link.springer.com/article/10.1186/s12967-016-1057-8 Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type M Alexander, ML Salgaller, E Celis, A Sette - American journal of , 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0002937896701102 Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein K Nilges, H Höhn, H Pilch, C Neukirch - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5464-5474.2003 Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization HW Chen, CH Leng, HY Liu, WF Cheng - Cancer Biology & , 2009 - Taylor & Francishttps://www.tandfonline.com/doi/pdf/10.4161/cbt.8.21.9732 Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A* 0201-restricted T-cell peptides in cervical cancer patients DW Liu, YC Yang, HF Lin, MF Lin, YW Cheng - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02256-06 Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens DB Keskin , B Reinhold , SY Lee, G Zhang - Frontiers in , 2011 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2011.00075/full Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations. CWF Cheng WenFang, LCN Lee ChienNan - 2005 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20053066734 Activated B cells mediate efficient expansion of rare antigen-specific T cells C Zentz, M Wiesner, S Man, B Frankenberger - Human immunology, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885906006112 Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy C Thornburg, D Boczkowski, E Gilboa - Journal of , 2000 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2000/07000/induction_of_cytotoxic_t_lymphocytes_with.4.aspx A Promising New Model: Establishment of Patient-Derived Organoid Models Covering HPV-Related Cervical Pre-Cancerous Lesions and Their Cancers B Hu, R Wang, D Wu, R Long, J Fan, Z Hu - Advanced , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/advs.202302340 Molecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptide AX Yang, N Chong, Y Jiang, J Catalano, RK Puri - PloS one, 2014 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086306

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP43487 H-YMLDL^QPETT-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.